← Eichor
Study identifier: NCT06177613 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Advantages of Early Intrauterine Transfer of "Blank" Culture Medium Prior to 1st or 2nd Transfer of Thawed Embryo(s).

Condition: Single Embryo Transfer · Fertilization in Vitro  ·  Sponsor: Centre Hospitalier Universitaire de Nīmes

PhaseNA
Planned participants1154
Who can joinFemale, N/A to no upper limit
Healthy volunteersNo

About this study

Despite technical advances in Medically Assisted Reproduction (AMP), the success of fertility treatments is sometimes limited by embryo implantation failure. The coordinated development of the embryo and the uterine endometrium requires close communication between the maternal tissue and the embryo. In in vitro fertilization (IVF), embryo transfer generally takes place between the 2nd (D2) and the 6th (D6) day following oocyte fertilization. Recent studies have shown the advantages of sequential transfer (transfer of an embryo on D2/D3 followed by the transfer of another embryo on D5/D6), with higher implantation and clinical pregnancy rate, fewer miscarriages, more live births, and yet no increase in multiple pregnancies. However, the American Society for Reproductive Medicine recommendations continue to prioritize the transfer of a single embryo for all patients aged under 38. To improve pregnancy rates for patients having a single embryo transferred, the study investigators wish to carry out on "blank" transfer, based on the principle of sequential transfer. The study investigators hypothesize that a culture medium, placed in the uterus before the time of embryo transfer, will modify immune tolerance. The study will test whether transferring the same culture medium in an equivalent quantity as during the real transfer into the uterus 2/3 days before the embryo transfer will improve tolerance to this foreign medium and, therefore, embryo implantation. The aim of this study …

This description comes directly from the study's public registry record.

Talk to the study team

Nathalie Rougier  ·  04.66.68.32.24  ·  nathalie.rougier@chu-nimes.fr

Always discuss trial participation with your own doctor first.

Locations (7)

Hôpital Antoine BéclèreClamart, FranceNot Yet Recruiting
Centre Hospitalier Alpes LémanContamine-sur-Arve, FranceNot Yet Recruiting
CHU Arnaud de VilleneuveMontpellier, FranceNot Yet Recruiting
Clinique Saint RochMontpellier, FranceNot Yet Recruiting
CHU de NîmesNîmes, FranceRecruiting
Clinique Saint-PierrePerpignan, FranceNot Yet Recruiting
CHU de la RéunionSaint-Pierre, ReunionNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06177613